Author
Listed:
- Manuela Pellegrini
(Experimental Immunology Branch, National Cancer Institute, National Institutes of Health)
- Arkady Celeste
(Experimental Immunology Branch, National Cancer Institute, National Institutes of Health)
- Simone Difilippantonio
(Experimental Immunology Branch, National Cancer Institute, National Institutes of Health)
- Rong Guo
(National Institute on Aging, National Institutes of Health)
- Weidong Wang
(National Institute on Aging, National Institutes of Health)
- Lionel Feigenbaum
(SAIC-Frederick, National Cancer Institute-Frederick Cancer Research and Development Center)
- André Nussenzweig
(Experimental Immunology Branch, National Cancer Institute, National Institutes of Health)
Abstract
The ATM (ataxia telangiectasia mutated) protein kinase is activated under physiological and pathological conditions that induce DNA double-strand breaks (DSBs). Loss of ATM or failure of its activation in humans and mice lead to defective cellular responses to DSBs, such as cell cycle checkpoints, radiation sensitivity, immune dysfunction, infertility and cancer predisposition. A widely used biological marker to identify the active form of ATM is the autophosphorylation of ATM at a single, conserved serine residue (Ser 1981 in humans; Ser 1987 in mouse)1. Here we show that Atm-dependent responses are functional at the organismal and cellular level in mice that express a mutant form of Atm (mutation of Ser to Ala at position 1987) as their sole Atm species. Moreover, the mutant protein does not exhibit dominant-negative interfering activity when expressed physiologically or overexpressed in the context of Atm heterozygous mice. These results suggest an alternative mode for stimulation of Atm by DSBs in which Atm autophosphorylation at Ser 1987, like trans-phosphorylation of downstream substrates, is a consequence rather than a cause of Atm activation.
Suggested Citation
Manuela Pellegrini & Arkady Celeste & Simone Difilippantonio & Rong Guo & Weidong Wang & Lionel Feigenbaum & André Nussenzweig, 2006.
"Autophosphorylation at serine 1987 is dispensable for murine Atm activation in vivo,"
Nature, Nature, vol. 443(7108), pages 222-225, September.
Handle:
RePEc:nat:nature:v:443:y:2006:i:7108:d:10.1038_nature05112
DOI: 10.1038/nature05112
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:443:y:2006:i:7108:d:10.1038_nature05112. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.